Market revenue in 2023 | USD 670.5 million |
Market revenue in 2030 | USD 2,522.4 million |
Growth rate | 20.8% (CAGR from 2023 to 2030) |
Largest segment | Oocytes |
Fastest growing segment | Sperm |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oocytes, Embryo, Sperm |
Key market players worldwide | Vitrolife AB ADR, Genea Biomedx, Immersion Corp, The Cooper Companies Inc, FUJIFILM Holdings Corp, BioTech Medics Inc, Nidacon, Minitube, Kitazato, VitaVitro Biotech |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vitrification market will help companies and investors design strategic landscapes.
Oocytes was the largest segment with a revenue share of 41.98% in 2024. Horizon Databook has segmented the Japan vitrification market based on oocytes, embryo, sperm covering the revenue growth of each sub-segment from 2018 to 2030.
The country is witnessing a low birth rate. According to the Health Ministry, the birth rate in 2022 was around 1.26, which decreased for the seventh successive year. This fertility rate is below the rate of 2.06–2.07, which is considered a requirement to maintain population. Thus, increasing infertility is a major issue across the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan vitrification market , including forecasts for subscribers. This country databook contains high-level insights into Japan vitrification market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account